Analysts/Institutional Investor Meet/Con. Call Updates

10th August, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Bandra Mumbai- 400 001 (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Sub: Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, We wish to inform you that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst/Institutional Investor Meetings with the Company is as under: Date Name of Analyst/Investor Nature of Meeting Mode Venue Meet 2nd September, Ashwamedh - Elara India Mumbai 2026 Dialogue 2026 17th September, Jefferies 5th India Forum Gurgaon Group / One-on-one 2026 Meeting (Investor Physical 18th September, Kotak Healthcare Forum Mumbai Conference) 2026 23rd and 24th Goldman Sachs Global Singapore September, Healthcare CDMO Day 2026 Note: Dates are subject to changes. Changes may happen due to exigencies on the part of Investors / Company. Kindly take the above on record. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com